Prognosis
U.S. Ships Gilead’s Remdesivir to More States for Hospital Use
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
The U.S. is sending Gilead Sciences Inc.’s remdesivir to local agencies in Connecticut, Illinois, Iowa, Maryland, Michigan and New Jersey after doctors raised questions about the federal allocation of the drug to treat Covid-19 patients.